Cleared Traditional

K760667 - 4-WAY STOPCOCK W/10 CM EXTEN. TUBING

K760667 is the FDA 510(k) clearance for 4-WAY STOPCOCK W/10 CM EXTEN. TUBING by American Viggo. It is a Class 2 General Hospital device (product code FMG) cleared through the Traditional 510(k) pathway after a 76-day FDA review.

K760667 · American Viggo · General Hospital
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Dec 1976
Decision
76d
Days
Class 2
Risk

K760667 is an FDA 510(k) clearance for the 4-WAY STOPCOCK W/10 CM EXTEN. TUBING. Classified as Stopcock, I.v. Set (product code FMG), Class II - Special Controls.

Submitted by American Viggo (Mchenry, US). The FDA issued a Cleared decision on December 2, 1976 after a review of 76 days - a notably fast clearance cycle.

This device falls under the General Hospital FDA review panel, regulated under 21 CFR 880.5440 - the FDA general hospital device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all American Viggo devices

Submission Details

510(k) Number K760667 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received September 17, 1976
Decision Date December 02, 1976
Days to Decision 76 days
Submission Type Traditional
Review Panel General Hospital (HO)
Summary -
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
53d faster than avg
Panel avg: 129d · This submission: 76d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code FMG Stopcock, I.v. Set
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 880.5440
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most General Hospital devices follow this clearance model.